5-Lipoxygenase-activating protein (FLAP) inhibitors. Part 4: development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once daily FLAP (Q42725382)
Jump to navigation
Jump to search
scientific article published on 7 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 5-Lipoxygenase-activating protein (FLAP) inhibitors. Part 4: development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once daily FLAP |
scientific article published on 7 November 2011 |
Statements
1 reference
5-Lipoxygenase-activating protein (FLAP) inhibitors. Part 4: development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once daily FLAP (English)
1 reference
Nicholas S Stock
1 reference
Gretchen Bain
1 reference
Jasmine Zunic
1 reference
Yiwei Li
1 reference
Jeannie Ziff
1 reference
Jeffrey Roppe
1 reference
Angelina Santini
1 reference
Janice Darlington
1 reference
Pat Prodanovich
1 reference
Christopher D King
1 reference
Christopher Baccei
1 reference
Catherine Lee
1 reference
Haojing Rong
1 reference
Charles Chapman
1 reference
Alex Broadhead
1 reference
Dan Lorrain
1 reference
Lucia Correa
1 reference
John H Hutchinson
1 reference
Jilly F Evans
1 reference
Peppi Prasit
1 reference
7 November 2011
1 reference
1 reference
Identifiers
1 reference